Alligator picks Cobra for cell line development of antibody candidate
Phase I trials of a candidate mAb cancer drug shows that regulators accept UCOE-based cell line engineering says Cobra Biologics.
Archives for June 1, 2015
Bubble delivery can rescue failing drug candidates, says Oxford team
University of Oxford scientists are saving undeliverable drugs by placing them in gas bubbles for better bioavailability and fewer side effects.
Pluristem outlines cell therapy production plan after securing patents in future markets
Pluristem Therapeutics will set up manufacturing sites and find local partners to make cell therapies for the Chinese, Korean, Mexican, Russian and Israeli markets after securing various patents this week.
Unique biologics pipelines driving biomanufacturing innovation, Deloitte says
The adoption of new technologies related to single-use bioreactors, disposable plastic containers, continuous purification processing, and real-time quality analysis are driving the next generation of biomanufacturing, according to a new report from the...